STAT April 29, 2024
Ed Silverman

Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and inspiring, because that oh-too predictable routine of online meetings, phone calls, and deadlines has returned. But what can you do? The world, such as it is, continues to spin. So to give it a nudge in a better direction, we are firing up the coffee kettle to brew some cups of stimulation. Our choice today is mocha almond. Please feel free to join us. Meanwhile, we have once again assembled a few items of interest for you. Best of luck on your journey today and, of course, do keep in touch….

MorphoSys is dealing with an emerging safety issue related to pelabresib, the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Wegovy could bankrupt US health system, Sanders says in new report
Uniquity Bio emerges with $300m for MSD immunology drug
Merck takes a slim lead in oncologists' perceptions amid a 'fiercely competitive' environment
Breaking down barriers for health system specialty pharmacies
Leqembi gets closer to being offered as an injection

Share This Article